Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Apps

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Science (New York, N.Y.)|April 6, 2013
Influence of HLA-C expression level on HIV controlRichard Apps, Ying Qi, Jonathan M Carlson, et al.
Nature Communications|June 8, 2021
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosusSarfaraz A Hasni, Sarthak Gupta, Michael Davis, et al.
Nature Immunology|December 19, 2022
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of childrenQin Xu, Pedro Milanez-Almeida, Andrew J Martins, et al.
Nature Immunology|January 5, 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE diseaseAhmet Ozen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Nature Communications|February 21, 2024
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndromeBrian Walitt, Komudi Singh, Samuel R LaMunion, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Science (New York, N.Y.)|April 6, 2013
Influence of HLA-C expression level on HIV controlRichard Apps, Ying Qi, Jonathan M Carlson, et al.
Nature Communications|June 8, 2021
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosusSarfaraz A Hasni, Sarthak Gupta, Michael Davis, et al.
Nature Immunology|December 19, 2022
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of childrenQin Xu, Pedro Milanez-Almeida, Andrew J Martins, et al.
Nature Immunology|January 5, 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE diseaseAhmet Ozen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Nature Communications|February 21, 2024
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndromeBrian Walitt, Komudi Singh, Samuel R LaMunion, et al.
Pageof 14